{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:20:28Z","timestamp":1793834428590,"version":"4.6.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100007505","name":"Kirsten og Freddy Johansens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3929-6","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T20:39:55Z","timestamp":1514407195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Outcome of breast cancer screening in Denmark"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4785-5236","authenticated-orcid":false,"given":"Elsebeth","family":"Lynge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"My","family":"von Euler-Chelpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Kroman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Lernevall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaj Borg","family":"Mogensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam Jan","family":"Wronecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Vejborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,28]]},"reference":[{"key":"3929_CR1","unstructured":"Engholm G, Ferlay J, Christensen N, Kejs AMT, Hertzum-Larsen R, Johannesen TB, Khan S, Leinonen MK, \u00d3lafsd\u00f3ttir E, Petersen T, Schmidt LKH, Trykker H, Storm HH. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 7.3 (08.07.2016). Association of the Nordic Cancer Registries. Danish Cancer Society. Available from. [Accessed on 4 May 2017]."},{"key":"3929_CR2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/aje\/kwi260","volume":"162","author":"NC Onland-Moret","year":"2005","unstructured":"Onland-Moret NC, Peeters PHM, van Gills CH, Clavel-Chapelon F, Key T, Tj\u00f8nneland A, Trichopoulou A, Kaaks R, Manjer J, Panico S, Palli D, Teherd B, Stoikidao M, Bueno-deMesquita HB, Boeing H, Overvad K, Lenner P, Quir\u00f3s JR, Chirlaque MD, Miller AB, Khaw KT, Riboli E. Age at menarche in relation to adult height. Am J Epidemiol. 2005;162:623\u201332.","journal-title":"Am J Epidemiol"},{"key":"3929_CR3","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/aje\/kww160","volume":"185","author":"NM Nielsen","year":"2017","unstructured":"Nielsen NM, Harps\u00f8e M, Simonsen J, Stenager E, Magyari M, Koch-Henriksen N, Baker JL, Hjalgrim H, Frisch M, Bager P. Age at menarch and risk of multiple sclerosis: a prespoctive cohort study based in the Danish national birth cohort. Am J Epidemiol. 2017;185:712\u20139.","journal-title":"Am J Epidemiol"},{"key":"3929_CR4","unstructured":"Danmarks Statistik. [Population development 2015]. K\u00f8benhavn: Danmarks Statistik, 2016. (in Danish)."},{"key":"3929_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12966-017-0517-8","volume":"14","author":"K Hoffmann","year":"2017","unstructured":"Hoffmann K, de Gelder R, Hu Y, Bopp M, Vitrai J, Lahelma E, Menvielle G, Santana P, Regidor E, Ekholm O, Mackenbach JP, van Lenthe FJ. Trends in educational inequalities in obesity in 15 European countries between 1990 and 2010. Int J Behaviour Nutr. 2017;14:63. doi: 10.1186\/s12966-017-0517-8 .","journal-title":"Int J Behaviour Nutr"},{"key":"3929_CR6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/02841861003602074","volume":"49","author":"K Rostgaard","year":"2010","unstructured":"Rostgaard K, V\u00e6th M, Rootz\u00e9n H, et al. Why did the breast cancer lymph node status distribution improve in Denmark in the pre-mammography screening period of 1978\u20131994? Acta Oncol. 2010;49:313\u201321.","journal-title":"Acta Oncol"},{"key":"3929_CR7","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0140-6736(93)91067-V","volume":"341","author":"L Nystr\u00f6m","year":"1993","unstructured":"Nystr\u00f6m L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryd\u00e9n S, Andersson I, Bjurstam N, Fagerberg G, Frisell J, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet. 1993;341:973\u20138. Erratum in: Lancet 1993;342:1372","journal-title":"Lancet"},{"key":"3929_CR8","unstructured":"Council recommendation of 2 December 2003 on cancer screening (2003\/878\/EC). Off J Eur Union L327\/34, 16.12.2003."},{"key":"3929_CR9","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/bjc.2013.177","volume":"108","author":"MG Marmot","year":"2013","unstructured":"Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M, The Independent UK Panel on Breast Cancer Screening. Thebenefits and hars oif breast cnacer screening: an independent review. Br J Cancer. 2013;108:2205\u201340.","journal-title":"Br J Cancer"},{"key":"3929_CR10","first-page":"4","volume":"59","author":"NE Day","year":"1989","unstructured":"Day NE, Williams DR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer. 1989;59:4\u20138.","journal-title":"Br J Cancer"},{"key":"3929_CR11","doi-asserted-by":"crossref","unstructured":"Perry N, Broeders M, de Wolf C, T\u00f6rnberg S, Holland R, von Karsa L. (Eds). European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition. Luxembourg: office for Offocial Publications of the European Comminities, 2006.","DOI":"10.1093\/annonc\/mdm481"},{"issue":"Suppl 83","key":"3929_CR12","first-page":"1","volume":"106","author":"E Lynge","year":"1998","unstructured":"Lynge E. Mammography screening for breast cancer in Copenhagen April 1991-march 1997. APMIS. 1998;106(Suppl 83):1\u201344.","journal-title":"APMIS"},{"issue":"Suppl 110","key":"3929_CR13","first-page":"1","volume":"111","author":"SH Njor","year":"2003","unstructured":"Njor SH, Olsen AH, Bellstr\u00f8m T, Dyreborg U, Bak M, Axelsson C, Graversen HP, Schwartz W, Lynge E. Mammography screening in the county of Fyn November 1993-December 1999. APMIS. 2003;111(Suppl 110):1\u201333.","journal-title":"APMIS"},{"key":"3929_CR14","unstructured":"Lov om \u00e6ndring af lov om sygehusv\u00e6senet (Tilbud om brystunders\u00f8gelse af kvinder mellem 50 og 69 \u00e5r). Vedtaget af Folketinget 17. December 1999. (in Danish)."},{"key":"3929_CR15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/bmj.38313.639236.82","volume":"330","author":"AH Olsen","year":"2005","unstructured":"Olsen AH, Njor SH, Vejborg I, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ. 2005;330:220.","journal-title":"BMJ"},{"key":"3929_CR16","unstructured":"Bekendtg\u00f8relse om ikrafttr\u00e6den af \u00a7 85, stk.1\u20133 i sundhedsloven om brystunders\u00f8gelse. 28. November 2008. (in Danish)."},{"issue":"6","key":"3929_CR17","first-page":"C4287","volume":"58","author":"I Vejborg","year":"2011","unstructured":"Vejborg I, Mikkelsen E, Garne JP, Bak M, Lernevall A, Mogensen NB, Schwartz W, Lynge E. Mammography screening in Denmark. Clinical guidelines. Dan Med Bull. 2011;58(6):C4287.","journal-title":"Dan Med Bull"},{"key":"3929_CR18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2147\/CLEP.S99467","volume":"8","author":"EM Mikkelsen","year":"2016","unstructured":"Mikkelsen EM, Njor SH, Vejborg I. Danish quality database on mammography screening. Clin Epidemiol. 2016;8:661\u20136.","journal-title":"Clin Epidemiol"},{"key":"3929_CR19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/ijc.20604","volume":"113","author":"A Jensen","year":"2005","unstructured":"Jensen A, Olsen AH, von Euler-Chelpin M, et al. Do nonattenders in mammography screening programmes seek mammography elsewhere? Int J Cancer. 2005;113:464\u201370.","journal-title":"Int J Cancer"},{"key":"3929_CR20","unstructured":"Dansk Kvalitetsdatabase for Brystkr\u00e6ftscreening. [Danish Quality database for breast cancer screening. Annual report 2015], Denmark, 2015. (in Danish)."},{"key":"3929_CR21","unstructured":"Dansk Kvalitetsdatabase for Brystkr\u00e6ftscreening. [Danish Quality database for breast cancer screening. Annual report 2016], Denmark, 2016. (in Danish)."},{"key":"3929_CR22","unstructured":"Statistics Denmark. www.statistikbanken.dk\/FOLK1A . Accessed 23 Oct 2017."},{"key":"3929_CR23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1258\/096914107781261891","volume":"14","author":"SH Njor","year":"2007","unstructured":"Njor SH, Olsen AH, Schwartz W, Vejborg I, Lynge E. Predicting the risk of a false- positive test for women following a mammography screening programme. J Med Screen. 2007;14:94\u20137.","journal-title":"J Med Screen"},{"key":"3929_CR24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00008469-200306000-00008","volume":"12","author":"E Lynge","year":"2003","unstructured":"Lynge E, Olsen AH, Fracheboud J, Patnick J. Reporting of performance indicators of mammography screening in Europe. Eur J Cancer Prev. 2003;12:213\u201322. Review","journal-title":"Eur J Cancer Prev"},{"key":"3929_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1472-6874-9-36","volume":"9","author":"KJ J\u00f8rgensen","year":"2009","unstructured":"J\u00f8rgensen KJ, Zahl P-H, G\u00f8tzsche PC. Overdiagnosis in organised mammography screening in Denmark. A comparative study. BMC Womens Health. 2009;9:36. doi: 10.1186\/1472-6874-9-36 .","journal-title":"BMC Womens Health"},{"key":"3929_CR26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0969141314563632","volume":"22","author":"SH Njor","year":"2015","unstructured":"Njor SH, Schwartz W, Blichert-Toft M, et al. Decline in breast cancer mortality: how much is attributable to screening? J Med Screen. 2015;22:20\u20137.","journal-title":"J Med Screen"},{"key":"3929_CR27","doi-asserted-by":"crossref","first-page":"c1241","DOI":"10.1136\/bmj.c1241","volume":"340","author":"KJ J\u00f8rgensen","year":"2010","unstructured":"J\u00f8rgensen KJ, Zahl P-H, G\u00f8tzsche PC. Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ. 2010;340:c1241.","journal-title":"BMJ"},{"key":"3929_CR28","unstructured":"Olsen AH, Njor S, Lynge E. http:\/\/www.bmj.com\/rapid-response\/2011\/11\/02\/re-j%C3%B8rgensen-et-al-breast-cancer-mortality-organised-mammography-screening . Accessed 10 Mar 2014."},{"key":"3929_CR29","doi-asserted-by":"crossref","first-page":"f1064","DOI":"10.1136\/bmj.f1064","volume":"346","author":"SH Njor","year":"2013","unstructured":"Njor SH, Olsen AH, Blichert-Toft M, Schwartz W, Vejborg I, Lynge E. Overdiagnosis in screening mammography in Denmark: population based cohort study. BMJ. 2013;346:f1064.","journal-title":"BMJ"},{"key":"3929_CR30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.7326\/M16-0270","volume":"166","author":"KJ J\u00f8rgensen","year":"2017","unstructured":"J\u00f8rgensen KJ, G\u00f8tzsche PC, Kalager M, Zahl P-H. Breast cancer screening in Denmark: a cohort study of tumor size and Overdiagnosis. Ann Intern Med. 2017;166:313. doi: 10.7326\/M16-0270 .","journal-title":"Ann Intern Med"},{"key":"3929_CR31","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0140-6736(94)90105-8","volume":"343","author":"R Boer","year":"1994","unstructured":"Boer R, Warmerdam P, de Koning H, van Oortmarssen G. Extra incidence caused by mammographic screening. Lancet. 1994;343:979. https:\/\/doi.org\/10.1016\/S0140-6736(94)90105-8 .","journal-title":"Lancet"},{"key":"3929_CR32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00008469-200504000-00007","volume":"14","author":"B M\u00f8ller","year":"2005","unstructured":"M\u00f8ller B, Weedon-Fekjaer H, Hakulinen T, Tryggvad\u00f3ttir L, Storm HH, Talb\u00e4ck M, et al. The influence of mammographic screening on national trends in breast cancer incidence. Eur J Cancer Prev. 2005;14:117\u201328.","journal-title":"Eur J Cancer Prev"},{"key":"3929_CR33","doi-asserted-by":"publisher","unstructured":"Lynge E, Beau AB, Christiansen P, von Euler-Chelpin M, Kroman N, Njor S, Vejborg I. Overdiagnosis in breast cancer screening: the impact of study design and calculations. Eur Cancer ;80:26\u201329. doi: 10.1016\/j.ejca.2017.04.018 . Epub 2017 ay 20.","DOI":"10.1016\/j.ejca.2017.04.018"},{"key":"3929_CR34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.canep.2015.05.004","volume":"39","author":"KK Jacobsen","year":"2015","unstructured":"Jacobsen KK, Abraham L, Buist DSM, Hubbard RA, O\u2019Meara ES, Sprague BL, Kerlikowske K, Vejborg I, von Euler-Chelpin M, Njor SH. Comparison of cumulative false-positive risk of screening mammography in the United States and Denmark. Cancer Epidemiol. 2015;39:656\u201363.","journal-title":"Cancer Epidemiol"},{"key":"3929_CR35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0748-7983(98)93320-0","volume":"24","author":"DA Grabau","year":"1998","unstructured":"Grabau DA, Jensen M-B, Blichert-Toft M, Andersen JA, Dyreborg U, Carstensen B, Al-Suliman NN, Graversen HP, Rose C. The importante of surgery and accurate axillary staging for survival in breast cancer. Eur J Surg Oncol. 1998;24:499\u2013507.","journal-title":"Eur J Surg Oncol"},{"key":"3929_CR36","doi-asserted-by":"crossref","unstructured":"Beau AB, Lynge E, Njor SH, Vejborg I, Lophaven S. Benefit-to-harm ratio of the Danish breast cancer screening programme. Int J Cancer 2017 May 3. doi: 10.1002\/ijc.30758. [Epub ahead of print] May 3. doi: 10.1002\/ijc.30758. [Epub ahead of print].","DOI":"10.1002\/ijc.30758"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3929-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T15:43:47Z","timestamp":1570549427000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3929-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3929"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3929-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"897"}}